Showing results (261-270 of 353) with videos related to
Sort By:
Pageof 36
Diabetic Medicine : a Journal of the British Diabetic Association|August 20, 2013
Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trialH W Rodbard, B Cariou, B Zinman, et al.Current Medicinal Chemistry|July 14, 2007
Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logsG Eelen, C Gysemans, L Verlinden, et al.Diabetes, Obesity & Metabolism|July 8, 2016
Efficacy and safety of triple therapy with dapagliflozin add-on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetesC Mathieu, M Herrera Marmolejo, J G González González, et al.Clinical and Experimental Immunology|December 1, 1988
Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic proteinG Torpier, J F Colombel, C Mathieu-Chandelier, et al.Pharmaceutical Research|February 1, 1997
Formulation of a charcoal suspension for intratumor injection. Part 1: Study of the nature, granulometry, and concentrationL Bonhomme-Faivre, M C Mathieu, J L Grossiord, et al.Diabetes, Obesity & Metabolism|November 8, 2012
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trialsR E Ratner, S C L Gough, C Mathieu, et al.Diabetologia|June 9, 2004
Human pancreatic duct cells can produce tumour necrosis factor-alpha that damages neighbouring beta cells and activates dendritic cellsB Movahedi, M Van de Casteele, N Caluwé, et al.Diabetes, Obesity & Metabolism|January 22, 2014
A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)C Mathieu, H W Rodbard, B Cariou, et al.European Journal of Pediatrics|August 10, 2012
Care delivery and outcomes among Belgian children and adolescents with type 1 diabetesK Doggen, N Debacker, D Beckers, et al.International Journal of Cancer|November 24, 1999
c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patientsM G Lê, M C Mathieu, S Douc-Rasy, et al.Pageof 36